NCT04753593

Brief Summary

Although it is now established that calcification process result from the joint and coordinated action of different cell types, many areas of shadow remain regarding the spatio-temporal implementation of these events. Highlighting these processes requires additional research to consider new approaches to clinical management of patients with such conditions. It is in this context that the investigators need to use residual human tissue fragments resulting from surgery which are not intended to be used for clinical-biological management of patients. The use of these pseudonymised human tissues will allow the investigators to conduct in vitro cell culture experiences.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 15, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

March 16, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

February 10, 2023

Status Verified

February 1, 2023

Enrollment Period

4.9 years

First QC Date

February 11, 2021

Last Update Submit

February 9, 2023

Conditions

Keywords

osteoblastVascular Calcificationvascular smooth muscle cellCardiac valve calcificationValvular interstitial cellbone tissue

Outcome Measures

Primary Outcomes (1)

  • Success in establishment of Cell Culture Systems from discarded surgery specimens

    Success in establishment of Cell Culture Systems from discarded surgery specimens

    5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The aortic wall and aortic valve discarded specimens will come from the Cardiac Surgery department of Amiens Picardie CHU. The bone and peri-bone discarded specimens will come from the orthopedic surgery services of the CHU Amiens-Picardie. The collection of samples and their use is part of various projects carried out by research project leaders supported by the laboratory MP3CV (CURS, site CHU sud, Amiens). No genomic analysis is planned for these samples. None clinical data is associated with the interpretation of data collected through the work that will be carried out from these human tissue samples. There are no collections per se, the samples collected are pseudonymized.

You may qualify if:

  • Patients undergoing surgery in the Cardiac Surgery and Orthopedic Surgery departments of the CHU Amiens-Picardie
  • patients who will be beforehand informed
  • patients who will not be opposed to this study.

You may not qualify if:

  • HIV and hepatitis positive patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80480, France

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

discarded human tissue fragments : vessel and bone tissue that are been harvested during surgery and which are not intended to be used for clinical-biological management of patients.

MeSH Terms

Conditions

Vascular Calcification

Condition Hierarchy (Ancestors)

CalcinosisCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2021

First Posted

February 15, 2021

Study Start

March 16, 2021

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

February 10, 2023

Record last verified: 2023-02

Locations